121 related articles for article (PubMed ID: 8330267)
1. Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66).
Antonini P; Linares G; Gaillard N; Venuat AM; Schlumberger M; Travagli JP; Caillou B; Berger R; Parmentier C
Cancer Genet Cytogenet; 1993 Jun; 67(2):117-22. PubMed ID: 8330267
[TBL] [Abstract][Full Text] [Related]
2. Karyotypic characterization of papillary thyroid carcinomas.
Roque L; Nunes VM; Ribeiro C; Martins C; Soares J
Cancer; 2001 Nov; 92(10):2529-38. PubMed ID: 11745186
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization.
Yang J; Qin LX; Li Y; Ye SL; Liu YK; Gao DM; Chen J; Tang ZY
Cancer Genet Cytogenet; 2005 Apr; 158(2):180-3. PubMed ID: 15796966
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid.
Olah E; Balogh E; Bojan F; Juhasz F; Stenszky V; Farid NR
Cancer Genet Cytogenet; 1990 Jan; 44(1):119-29. PubMed ID: 2293877
[TBL] [Abstract][Full Text] [Related]
5. [The growth activity and DNA ploidy in anaplastic carcinoma transplanted to nude mice].
Yoshida A; Asaga T; Masuzawa C; Kawahara S; Yanoma S; Shimizu A; Harada M
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):177-81. PubMed ID: 8464414
[TBL] [Abstract][Full Text] [Related]
6. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic abnormalities in a patient with hypercalcemia and papillary thyroid carcinoma.
Pathak S; Hsu TC; Samaan N; Hickey RC
Hum Genet; 1982; 60(3):291-3. PubMed ID: 7106763
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line.
Dettori T; Frau DV; Garcia JL; Pierantoni G; Lee C; Hernandez JM; Fusco A; Morton CC; Vanni R
Cancer Genet Cytogenet; 2004 Jun; 151(2):171-7. PubMed ID: 15172756
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
[TBL] [Abstract][Full Text] [Related]
10. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.
Jenkins RB; Hay ID; Herath JF; Schultz CG; Spurbeck JL; Grant CS; Goellner JR; Dewald GW
Cancer; 1990 Sep; 66(6):1213-20. PubMed ID: 2400971
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic findings in 31 papillary thyroid carcinomas.
Roque L; Clode AL; Gomes P; Rosa-Santos J; Soares J; Castedo S
Genes Chromosomes Cancer; 1995 Jul; 13(3):157-62. PubMed ID: 7669734
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic study of a nodular hyperplasia of the thyroid after irradiation for Hodgkin's disease.
van den Berg E; van Doormaal JJ; Oosterhuis JW; de Jong B; Buist J; Vos AM; Dam A; Vermeij A
Cancer Genet Cytogenet; 1991 May; 53(1):15-21. PubMed ID: 2036636
[TBL] [Abstract][Full Text] [Related]
13. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
[TBL] [Abstract][Full Text] [Related]
14. Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease.
Sturgis CD; Caraway NP; Johnston DA; Sherman SI; Kidd L; Katz RL
Cancer; 1999 Jun; 87(3):155-60. PubMed ID: 10385447
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases.
Copland JA; Marlow LA; Williams SF; Grebe SK; Gumz ML; Maples WJ; Silverman VE; Smallridge RC
Thyroid; 2006 Dec; 16(12):1293-302. PubMed ID: 17199440
[TBL] [Abstract][Full Text] [Related]
16. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
[TBL] [Abstract][Full Text] [Related]
17. A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid.
Antonini P; Venuat AM; Linares G; Caillou B; Berger R; Parmentier C
Cancer Genet Cytogenet; 1989 Aug; 41(1):139-44. PubMed ID: 2766248
[TBL] [Abstract][Full Text] [Related]
18. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
[TBL] [Abstract][Full Text] [Related]
19. Molecular rearrangements in papillary thyroid carcinomas.
Zitzelsberger H; Bauer V; Thomas G; Unger K
Clin Chim Acta; 2010 Mar; 411(5-6):301-8. PubMed ID: 19958753
[TBL] [Abstract][Full Text] [Related]
20. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
